GlassScriptPhysician profile
William O Cornwell
NPI 1578540654
$8,920.79
in general payments reported to CMS, 2019-2025
51 companies · $56.75 in 2025
The $56.75 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,966 · 2020: $1,250 · 2021: $2,156 · 2022: $1,900 · 2023: $1,439 · 2024: $153 · 2025: $56.75.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,649.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,649.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $767.91 | 2019-2023 | Ozempic, Rybelsus |
| Amgen INC. | $761.87 | 2019-2023 | Repatha, Otezla, Prolia |
| Pfizer INC. | $738.59 | 2019-2023 | |
| Amarin Pharma, INC. | $566.23 | 2019-2023 | |
| Glaxosmithkline, LLC. | $537.40 | 2019-2023 | Trelegy Ellipta, Shingrix, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $526.86 | 2019-2023 | Jardiance, Ofev |
| Abbott Laboratories | $440.72 | 2019-2024 | Thoratec Heartmate 3 Lvas Implant Kit, Freestyle Libre 3 |
| Sanofi-Aventis U.S. LLC | $428.61 | 2019-2023 | |
| Astellas Pharma US INC | $392.00 | 2019-2024 | Veozah, Myrbetriq |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $378.97 | 2019-2023 | Trulance, Xifaxan |
| Abbvie INC. | $312.11 | 2020-2023 | Ubrelvy, Vraylar |
| Astrazeneca Pharmaceuticals LP | $263.07 | 2019-2021 | |
| Lilly USA, LLC | $229.69 | 2019-2023 | Mounjaro |
| Merck Sharp & Dohme LLC | $220.17 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $159.56 | 2019-2023 | Camzyos, Eliquis |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Cornwell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.